NCT06131112View on ClinicalTrials.gov

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis

RecruitingOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions
Cardiac Sarcoidosis
Interventions
DIAGNOSTIC_TEST

64Cu-DOTATATE PET/CT scan

Patients in group A-C will have a 64Cu-DOTATATE PET/CT scan performed in addition to routine clinical procedures. Group D has had 64Cu-DOTATATE PET/CT performed as part of their clinical diagnostic work-up or follow-up; these data are retrospectively identified and included in the study, and group D will not be subject to any scans in the study.

Trial Locations (1)

Unknown

RECRUITING

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER